Diversity & Inclusion

Accelerating Global Access

Our company is collaborating with a range of partners to enable access for patients around the world
Dec 13, 2021 8:20 AM ET
Accelerating Global Access infographic

Originally published by Merck

At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.

Here’s how we have been working to fulfill that commitment.

Merck & Co., Inc. logo

More from Merck & Co., Inc.

How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together

Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region

Merck Is Inspiring Innovation Through Diversity and Inclusion

The Wall Street Journal Names Merck Among Top 10 Best-Managed Companies

Unexpected Inspiration for More Sustainable Drug Development at Merck

Merck Ranks No. 1 on Newsweek’s List of America’s Most Responsible Companies 2024

Merck Senior Vice President Sarah Aiosa Named to Most Powerful Latinas List

Merck Is Collaborating To Address Antimicrobial Resistance